ENTBF
PINK Entheon Biomedical Corp.$0.0300 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0300, and at the day’s high of $0.0300
- YTD change
- +710.81%
- vs 20-day SMA
- +196.00%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.03 (+710.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 71.1% away from all-time highs of $0.1038
- ENTBF is up 711% since the beginning of the year
- ENTBF is up 711% over the past 12 months
- ENTBF is up 711% over the past 1 month
- 0% of all ENTBF investors are betting against ENTBF
ENTBF reads n/a: the 12-month move is -53.8%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0259
- Last 5 days
- +50.00%
- vs 8-day SMA
- +167.56%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.